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Acid-base and metabolic responses to anion infusion in the
anesthetized dog
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Acid-base and metabolic responses to anion infusion in the anesthetized
dog. This study evaluated the acid-base and metabolic effects of several
organic anions which might have application in the correction of
metabolic acidosis during hemodialysis. Anesthetized dogs were in-
fused intravenously with the sodium salts of either chloride, bicarbon-
ate, acetate, lactate, or pyruvate. Acetate perturbated metabolism more
than any of the other organic anions infused. These perturbations
included hypoxemia, reductions in serum potassium and phosphorus, a
decrease in plasma glucose, and increases in intermediary metabolites
such as lactate, acetoacetate and 3-hydroxybutyrate. Transferance of
our findings to hemodialysis suggests that acetate would compromise
the ability of dialysis to reduce body burdens of potassium and
phosphorus and provide proper base repletion. Pyruvate would appear
superior to acetate as a base substitute by virtue of its lesser effects on
oxygen consumption and electrolyte distribution and its capacity to
produce glucose. However, the significant production of lactate with
pyruvate infusion, coupled with diffusive losses of bicarbonate during
dialysis and the possible instability of pyruvate in solution, would still
hinder proper base repletion. Bicarbonate generation with lactate
infusion was too slow to provide a practical alternative for base
repletion in hemodialysis. Bicarbonate infusion caused minimal alter-
ations in intermediary metabolism. This, in conjunction with obviating
diffusive losses, suggests the use of bicarbonate would allow more
appropriate base repletion during hemodialysis.
Effets acidobasiques et metaboliques de Ia perfusion d'anions chez le
chien anestheie. Cette étude a évalud les effets acidobasiques et métabo-
liques de plusieurs anions organiques qui pourraient avoir une indica-
tion dans Ia correction de l'acidose métabolique au cours de l'hémodia-
lyse. Des chiens anesthesiés ont été perfusds par voie intraveineuse
avec des sels sodiques de chiore, bicarbonate, acetate, lactate ou
pyruvate. L'acétate a perturbC Ic mCtabolisme beaucoup plus que tous
les autres anions organiques perfusés. Ces perturbations consistaient en
une hypoxie, en une diminution de Ia phosphorCmie, une diminution de
Ia glycemie, et une augmentation de mCtabolites intermédiaires tels Ic
lactate, l'acdtoacétate et Ic béta-hydroxybutyrate. L'extrapolation de
nos résultats a l'hCmodialyse suggCre que l'acdtate pourrait compro-
mettre Ia capacité de Ia dialyse de rCduire les stocks potassique et
phosphore de l'organisme et d'obtenir une repletion correcte en bases.
Le pyruvate apparaitrait meilleur que l'acétate en tan que substitut
basique, en raison de ses maindres effets sur Ia consommation d'oxy-
gene, la distribution electrolytique et de sa capacitC a produire du
glucose. Cependant, Ia production significative de lactate lors d'une
perfusion de pyruvate, couplde aux pertes diffusionnelles de bicarbon-
ate au cours de Ia dialyse, et a la possible instabilité du pyruvate en
solution pourrait encore compromettre une repletion basique correcte.
La gCnération de bicarbonate aprés perfusion de lactate Ctait trop lente
pour offrir une solution pratique a la rCplCtion basique au cours de
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l'hemodialyse. La perfusion de bicarbonate a entrainC des alterations
minimes du mCtabolisme intermddiaire. Ce fait, joint a la correction des
pertes diffusionnelles en bicarbonate suggere que l'utilisation des
bicarbonates pourrait permettre une répldtion plus correcte en bases au
cours de l'hemodialyse.
Administration of nonbicarbonate organic anions has long
been recognized as a means of supplying base in the clinical
treatment of metabolic acidosis. Perhaps nowhere has this been
more common than in the use of sodium acetate in the dialytic
therapy of uremic patients. The use of sodium acetate for this
purpose began in 1964 [11, when its physicochemical attributes
were found superior to those of sodium bicarbonate for large-
scale dialysis.
However, sodium acetate may not provide totally adequate
base repletion in hemodialysis patients. Use of a nonbicarbon-
ate containing dialysate causes diffusive losses of bicarbonate
from the patient during treatment. Further, intermediary metab-
olites such as lactate, acetoacetate, and 3-hydroxybutyrate are
produced and lost diffusively in significant quantities during
acetate dialysis [2, 3]. These factors, together, may serve to
stress the metabolic capacity of dialysis patients to correct their
acid-base imbalance, an allusion to the so-called acetate intoler-
ance [4].
Sodium acetate has also been implicated as a contributing
factor in cardiovascular instability observed in uremic patients
during dialysis [5]. A recent study by Liang and Lowenstein [6]
suggests that accumulation of AMP and adenosine in the dog
myocardium and striated muscle, a consequence of cleavage of
ATP to form acetyl-CoA from acetate, causes increased cardiac
output and decreased peripheral resistance following the admin-
istration of sodium acetate.
Recognizing these aspects of acetate metabolism, the present
work was undertaken to define the relative effects compared to
sodium chloride of infusions of the sodium salts of several
organic anions, bicarbonate, acetate, lactate and pyruvate, on
acid-base response, and intermediary metabolism in the nondia-
lyzed anesthetized dog. Our objective was to develop a ratio-
nale for the choice of anion used in clinical hemodialysis based
upon the comparative aspects of the metabolism of these four
organic anions.
The results of our work show that minimal perturbation of
intermediary metabolism occurred with bicarbonate infusion
while equimolar acetate infusion markedly stimulated interme-
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diary metabolism and generated less bicarbonate. Lactate and
pyruvate stimulated intermediary metabolism to a lesser degree
than acetate even though pyruvate caused comparable changes
in bicarbonate generation. We conclude that indeed acetate, by
virtue of the nature of its metabolism, is not the optimal organic
anion for correcting metabolic acidosis in the dialysis patient.
Methods
Adult dogs weighing 11 to 38 kg were fasted but given free
access to water for 48 hr before being anesthetized to an
areflexic plane of anesthesia with sodium pentobarbital (26
mg/kg, i.v., Abbott Laboratories, Chicago, Illinois). Supple-
mental doses of sodium pentobarbital were given intravenously
as needed to maintain this plane of anesthesia. The dogs were
intubated and maintained on a dual cylinder Harvard animal
ventilator (Harvard Apparatus Co., Millis, Massachusetts). The
respiratory minute volume was adjusted to maintain a PaCO2 in
the range of 30 to 45 mm Hg and a Pa02 in the range 80 to 100
mm Hg. The necessary minute volume of ventilation was
largely dependent on dog body weight and ranged between 2.4
to 6.1 liter/mm. The femoral artery and vein of the right hind leg
were cannulated with 2.3 mm diameter polyethylene tubing.
The arterial cannula was connected to a P23Db Statham pres-
sure transducer (Gould Inc., Oxnard, California) and the signal
fed into a Beckman R612 Dynograph recorder (Beckman Instru-
ments, Schiller Park, Illinois) to measure blood pressure.
Arterial blood samples were obtained through this same cannu-
Ia. The venous cannula was used for intravenous infusion with a
Sage 355 syringe pump (Orion Research Inc., Cambridge,
Massachusetts). The dog's ureters were located through a
midline incision, ligated immediately above the bladder, and
cannulated antegrade with 1.67 mm diameter polyethylene
tubing. Total urine output was obtained from timed collections
in graduated cylinders.
Arterial blood gases and pH were measured with a Radiome-
ter BM3-Mk2 blood gas analyzer (Radiometer Co., Copenha-
gen, Denmark). Blood bicarbonate levels were subsequently
calculated from arterial pH and PaCO2 using the Henderson-
Hasselbalch equation and a pK of 6.1. Serum sodium, potassi-
um, chloride, inorganic phosphorus, glucose, and albumin were
determined by standard clinical laboratory methods. Enzymatic
methods were used to determine alanine [7], lactate [8], pyru-
vate [9], acetoacetate [10], and 3-hydroxybutyrate [11] in the
supernatant of perchloric acid precipitated whole blood. Plasma
immunoreactive insulin was determined by radioimmunoassay
[12] and plasma acetate by an enzymatic method [131.
The experimental animals were divided into five groups of six
dogs. Following a 30-mm control period during which all groups
were infused with physiological saline, groups were infused
with the sodium salts of either chloride, bicarbonate, acetate,
lactate, or pyruvate to a total dose of 10 mmoles/kg in 60 mm.
This dose was chosen to approximate on a per weight basis the
total load of acetate received by a patient during hemodialysis
[14]. Following anion infusion, all groups were followed for a
30-mm recovery period during which physiological saline was
again infused. Volumetric infusion rates were kept constant
throughout each experiment at 0.167 mI/mm/kg.
Blood was sampled for blood gases, pH, electrolytes, glu-
cose, and albumin at 0, 10, and 20 mm during the control period,
at 10, 20, 30, 40, and 60 mm during the anion infusion period,
and at 15 and 30 mm during the recovery period. Lactate,
pyruvate, acetoacetate and f3-hydroxybutyrate levels were de-
termined at 0 and 20 mm in the control period, 20, 40, and 60
mm in the anion infusion period, and 30 mm in the recovery
period. Blood levels of alanine and plasma levels of acetate and
insulin were determined at 10 mm in the control period and at
the end of the anion infusion and recovery periods.
Because hypertonic solutions (1 M) were administered during
the anion infusion period, fluid shifts were induced from the
extravascular to the vascular space causing dilution of blood
solutes. Recognizing that the dog's spleen is a reservoir of red
blood cells which may serve to autotransfuse the animal in an
unpredictable manner with blood letting, serum albumin con-
centration at any time rather than the hematocrit level was
chosen as a reasonable indicator of changes in vascular volume.
More importantly, albumin, as a colloid, permitted correction
for dilutional effects on the serum or blood concentration of any
substance measured due to the induced osmotic shifts of fluid
following infusion of the 1 M sodium solutions. Because it
would be unlikely that albumin could be either extravasated,
produced, or catabolized significantly during the present short-
term experiments, solute levels at each sampling time were
normalized by the ratio of serum albumin at that time to the
control value. This is similar to the method described by
Chinard, Vosburgh, and Enns [15] who accounted for changes
in solute concentrations due to fluid shifts induced by the
infusion of hypertonic solutions by factoring solute concentra-
tions using those of a reference solute known to distribute only
in the vascular space. Blood gas and acid-base parameters were
not normalized by serum albumin ratios because any unmea-
sured perfusion/diffusion changes in the lungs would also affect
their values. In addition, the final levels of hydrogen ion and
bicarbonate reflect to some extent isohydric linkage to all body
buffer systems.
Where applicable, control measurements were averaged to
give a mean control value for each parameter. pH values were
converted to hydrogen ion concentrations to facilitate statistical
analysis. Between group differences in the mean control values
were assessed by analysis of the variance [16]. The statistical
significance of changes in solute levels from control values
during the anion infusion and recovery periods was assessed
between groups by analysis of covariance and within groups by
Student's t test for paired data [16]. Changes were considered
significant if 2P values were less than 0.05. Values are given as
mean SEM for N observations.
Results
While serial samples were obtained, only control values and
values at the ends of the infusion and recovery periods are
presented unless transient changes justify further comment. As
outlined in the methods section, solute concentrations were
factored by the ratios of experimental to control albumin levels
to correct for fluid shifts. Analysis of covariance was performed
on both the corrected and uncorrected data. There were no
qualitative differences between the results of these analyses.
However, the corrected data showed less variation between
one experiment and another for a particular infusate than did
the uncorrected data.
Fluid balance determinations, estimates of changes in vascu-
lar volume, and mean blood pressure responses. Changes in
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Table 1. Control body weights, serum albumin concentrations, and mean blood pressures and percentage changes following chloride,
bicarbonate, acetate, lactate, and pyruvate infusions
Infusate
Chloride Bicarbonate Acetate Lactate Pyruvate
Body weight
Control, kg 23.8 3.0 25.8 2.7 23.0 2.0 23.5 4.0 16.8 1.9
Percent change
End infusion 0.08 0.30 0.08 0.21 0.35 0.09 0.19 0.27 —0.08 0.14
Percent change
End recovery —0.18 0.44 —0.07 0.30 0.07 0.21 0.07 0.41 —0.28 0.16
Serum albumin concentration
Control, gld! 2.9 0.1 3.2 0.2 3.1 0.2 2.7 0.1 2.7 0.1
Percent change
End infusion —18.9 2.4 —12.2 2.9 —6.5 3.8b —12.1 1.9 —8.6 1.8"
Percent change
End recovery —13.1 1.8 —9.7 2.9 —8,6 2.9 —10.1 0.9 —8.5 2.2
Mean BP
Control, mm Hg 136 6 123 5 124 4 121 13 133 6
Percent change
End infusion 1.6 1.4 —2.9 2.9 —22.8 9,9b,c 1.6 4.2d —0.8 3.Od
Percent change
End recovery 1.3 1.9 —3.0 3.1 —22.2 6.91s.c 1.5 49J —6.8 39d
Values are mean SEM. Each group was comprised of 6 dogs. All experiments consisted of a 60-mm infusion at a rate of 0.167 mmoles/kg/min
followed by a 30-mm recovery period. Control values were compared by analysis of variance [18]. There were no significant differences in control
values between groups. Changes from control values at the end of infusion and recovery were compared between groups by analysis of covariance
[18] with 2P < 0.05 being considered significant. Symbols indicate the following significant between-group differences:
b Different from chloride.
Different from bicarbonate.
d Different from acetate.
Different from lactate.
body weight, serum albumin concentration, and mean blood
pressure during and following the infusion of each anion are
given in Table 1. Changes in body weight, reflecting changes in
the state of hydration, were small and overall averaged —0.09
0.14% (N = 30) over the duration of the experiment. This
indicates that, on a volume basis, the amount of fluid infused in
each experiment approximated losses due to blood sampling
and urine excretion. Although not shown in Table 1, urine flow
rates were comparable and did not differ with statistical signifi-
cance between groups before, during, and following anion
infusion. Further, the maximum average diuresis observed in
any group during or following infusion was 5.6 2.3 mllmin,
indicating that urinary losses did not materially affect the blood
levels of any given substance.
Figure 1 shows percentage changes in serum albumin levels
during the time of the experiments and illustrates the dilutional
effects on serum albumin in a dynamic manner. This provides
the rationale for normalization of blood solute levels following
intercompartmental fluid shifts. Sodium acetate had the least
dilutional effect on albumin levels (—6.5 3.8%, NS, at the end
of infusion) while sodium chloride had the greatest dilutional
effect (—18.9 2.4%, 2P < 0.001, at the end of infusion). The
remaining anions exhibited intermediate dilutional effects on
serum albumin. Following the infusion of each anion, there was
either stabilization of albumin levels, such as with acetate, or a
definite return toward pre-infusion levels, such as with chlo-
ride.
The mean arterial BP data in Table 1 demonstrate that acetate
had a depressant effect on BP (—22.8 9.9% at the end of
infusion) causing BP changes in this group of dogs to differ with
statistical significance (2P < 0.01) from all other groups.
Arterial hydrogen ion, blood gases, and bicarbonate changes
in response to anion infusion. The data in Table 2 give average
values for these parameters. Because all data were obtained in
the presence of constant ventilation, changes in these parame-
ters reflect changes in acid-base states or oxygenation due
primarily to the infusate directly (chloride, bicarbonate) or
additionally to associated changes in metabolism (acetate,
lactate, pyruvate).
Infusion of sodium chloride was characterized by a small but
significant increase in a hydrogen ion concentration of 3.7 1.1
nmoles/liter (2P < 0.025). Pa02 tended to increase on the
average but without statistical significance. In contrast, sodium
bicarbonate infusion resulted in a marked alkalemia with aver-
age increases in PaCO2 and arterial bicarbonate of 10.1 2.2
mm Hg and 15.9 1.9 mmoles/liter, respectively, resulting in
an average decline in the hydrogen ion level of 12.9 1.5
nmoles/liter (2P < 0.001). Pa02 decreased on the average by
15.0 4.7 mm Hg (2P <0.025) at the end of infusion.
Similar degrees of alkalemia were induced with infusions of
acetate and lactate as with bicarbonate. However, there were
several marked quantitative differences in the generation of
dissolved carbon dioxide and bicarbonate. While PaCO2 de-
creased somewhat initially with acetate infusion, thereafter, it
rose essentially in parallel with the changes observed with
bicarbonate and pyruvate infusions. It is apparent from the data
in Table 2 that lactate was much less effective in generating
dissolved carbon dioxide, as reflected by changes in PaCO2,
than bicarbonate infusions (2P < 0.005). This lesser rate of
generation of dissolved carbon dioxide with lactate infusion was
responsible for achieving the similar degrees of alkalemia on
comparing infusions of bicarbonate, acetate, and lactate. The
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Fig. 1. Percentage change from control values in serum albumin during
infusions of sodium chloride (0), sodium bicarbonate (•), sodium
acetate (is), sodium lactate (A), and sodium pyruvate (0) at a rate of
0.167 mmoles/min/kg for a 60-mm infusion period followed by infusion
of normal saline at a rate of 0.167 mI/mm/kg for a 30-mm recovery
period in groups of six pentobarbital anesthetized dogs maintained on
constant ventilation.
bicarbonate levels following lactate infusion, while increased
significantly (2P < 0.001) at the end of infusion, were substan-
tially and significantly less than those achieved with acetate
infusion (2P < 0.025) and bicarbonate infusion (2P < 0.001).
Pa02 levels decreased profoundly following acetate infusion
and to a significantly greater extent than with either bicarbonate
(2P < 0.05) or lactate (2P < 0.001). Infusion of pyruvate did not
produce a statistically significant alkalemia until the end of the
recovery period (2P < 0.01) with hydrogen ion concentrations
having decreased by only 6.6 3.2 nmoles/liter at the end of
infusion. The reason for the comparatively lesser degree of
alkalemia following pyruvate infusion is apparent on observing
changes in PaCO2. PaCO2 levels increased with pyruvate
infusion to a degree comparable to those observed with bicar-
bonate infusion and to a much greater extent than those
observed with either acetate or lactate. Thus, despite the fact
that the generation of bicarbonate with pyruvate was identical
to that observed with acetate infusion, the reduction in hydro-
gen ion level was significantly less (2P < 0.05). Pyruvate
infusion did not cause a significant decrease in Pa02 until the
end of the recovery period (2P < 0.01) and this effect was
significantly less than that of acetate (2P < 0.001).
Electrolyte and glucose changes in response to anion infu-
sions. The data in Table 3 relate average values for electrolytes,
phosphorus, and glucose. Serum sodium levels rose in response
to all infusions; however, the increase observed with chloride
was significantly greater than that observed with acetate (2P <
0.01) and pyruvate (2P < 0.05). Although the data are not
shown, serum chloride levels increased in proportion to serum
sodium levels with chloride infusion, rising from a control value
of 114 ito 169 6 m at the end of infusion. Serum chloride
did not change from control levels with acetate infusion and, on
the average, rose only modestly by about 7 1% with infusions
of bicarbonate, lactate, and pyruvate.
Serum potassium rose markedly with chloride infusion (19
6%) but declined with bicarbonate (—11 4%), lactate (—15
3%), pyruvate (—19 4%), and acetate (—25 5%) infusions.
The decline in serum potassium was significantly greater with
acetate than with bicarbonate (2P < 0.05), while lactate and
pyruvate infusions, which resulted in intermediate decreases,
did not differ with statistical significance from those with
infusions of either bicarbonate or acetate. Serum phosphorus
either increased (chloride, 2P < 0.05; bicarbonate, 2P < 0.05),
decreased (acetate, 2P < 0.025), or remained unchanged (lac-
tate, pyruvate) at the end of infusion. Pyruvate initially caused a
significant increase in serum phosphorus (2P <0.025)10 to 30
mm into the infusion period; however, this increase was dissi-
pated by the end of infusion. By virtue of the divergent
responses, intergroup comparisons resulted in several statisti-
cally significant differences on comparison of acetate, lactate,
and pyruvate to chloride and bicarbonate (Table 3).
Serum glucose increased with statistical significance by ei-
ther the end of the infusion or recovery periods with chloride
(2P < 0.001), bicarbonate (2P < 0.05), lactate (2P < 0.005), and
pyruvate (2P < 0.05). Only acetate infusion caused a significant
decline (2P < 0.05) in serum glucose at the end of infusion. The
intergroup statistical comparisons are as indicated in Table 3.
Changes in intermediary metabolites in response to anion
infusions. The data in Table 4 depict the changes in blood levels
of pyruvate, lactate, acetoacetate and -hydroxybutyrate in
response to the anion infusions. Chloride infusion did not
significantly affect blood levels of any of these intermediates,
while bicarbonate caused a significant increase only in lactate
levels (2P < 0.01) at the end of infusion. On the average, acetate
infusion tended to reduce pyruvate levels, while significantly
increasing the blood levels of lactate (2P < 0.001), acetoacetate
(2P < 0.001), and -hydroxybutyrate (2P <0.025) at the end of
infusion. In contrast, lactate and pyruvate infusions had no
statistically significant effect on blood levels of acetoacetate
and 3-hydroxybutyrate but caused significant increases in
blood lactate (2P < 0.005 and 2P < 0.001, respectively) and
pyruvate (2P <0.025 and 2P <0.001, respectively) at the end of
infusion. The intergroup statistical comparisons are as indicated
in Table 4.
Changes in blood alanine and plasma acetate and insulin
levels in response to anion infusions. The data in Table 5 give
average values for blood alamne and plasma acetate and insulin
levels in the control period and at the end of the infusion and
recovery periods. Chloride infusion did not affect the levels of
any of these parameters, while bicarbonate was associated with
a significant decline in alanine levels by the end of the recovery
period (2P < 0.05). Acetate infusion was associated with a
significant decline in blood alanine which was sustained to the
end of the recovery period (2P < 0.05) and, as expected, a
marked increase in plasma acetate (2P < 0.025). Plasma insulin
levels were sustained during acetate infusion but declined
sharply on cessation of infusion (2P < 0.005). Lactate infusion
did not significantly affect blood alanine or plasma insulin levels
but caused a significant increase in plasma acetate concentra-
tions (2P < 0.05). Pyruvate infusion was associated with a
significant increase in blood alanine, sustained to the end of the
recovery period (2P < 0.05), and modest increases in the levels
of plasma acetate (2P < 0.05) and insulin (2P < 0.05). Inter-
group comparisons relating statistically significant changes fol-
Time, mm
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Table 2. Arterial blood gas and acid-base parameters following chloride, bicarbonate, acetate, lactate, and pyruvate infusionsa
Infusate
Chloride Bicarbonate Acetate Lactate Pyruvate
Hydrogen ion, flM
Control 44.7 1.3 43,9 1.0 45.2 1.7 43.5 1.3 49.3 1.3
End infusion 48.4 1.6 31,0 1.8b 32.3 l.3b 324 1.7 42.7 3,9b.cd
End recovery 48.6 1.7 33.3 l.6 33.1 l.Ob 32.0 1.8b 38.8 2.7b
PaCO2, mm Hg
Control 39.0 2.2 34.1 1.6 37.5 1.2 33.2 1.6 40.7 1.3
End infusion 37.3 2.0 44.2 1,7b 42.1 2,2b 34.8 2.l' 52.5 3,9b,d.e
End recovery 37.1 2.4 39.5 l.8b 42.7 l.9b 36.3 2.1" 47,5 2.3"
Bicarbonate, m
Control 20.8 0.9 18.6 0.6 19.9 0.7 18.1 0.8 19.6 0.7
End infusion 18.8 0.7 34.5 1.5b 30.0 1.lbc 25.6 l.Ob.c.d 29.6 l,2b.c.
End recovery 18.1 0.7 28.3 1.1" 30.7 0.6" 27.1 0.9" 29.5 lOb
Pa02, mm Hg
Control 81.3 2.8 79.6 3.8 80.0 1.1 81.3 2.2 86.6 2.6
End infusion 82.9 1.3 64.6 1.9" 53.5 2.4" 70.5 2.7" 73.9 4.2b'd
End recovery 83.9 2.7 72.0 4.9" 57.8 l.3b,c 68.5 2.9" 74.3 45b.d
The experimental design, number of dogs, presentation of data, and notation of symbols are the same as in Table 1.
Table 3. Arterial serum sodium, potassium, inorganic phosphorus, and glucose following chloride,
bicarbonate, acetate, lactate and pyruvate in1usions
Infusate
Chloride Bicarbonate Acetate Lactate Pyruvate
Sodium, mM
Control 149 1 149 1 149 1 146 1 150 1
End infusion 206 7 187 7 177 9b 183 6 185 4"
End recovery 186 4 179 6 175 6 176 4 177 6
Potassium, m
Control 4.3 0.1 4.5 0.1 4.4 0.3 4.5 0.1 4.0 0.1
End infusion 5.0 0.3 4.0 0.1" 3.3 0.2" 3.9 0.2" 3.2 0.2"
End recovery 5.1 0.2 4.0 0.1" 3.4 0.2" 3.8 0.3b 3.5 0.2"
Inorganic phosphorus, mM
Control 1.63 0.09 1.66 0.09 1.63 0.16 1.66 0.13 1.75 0.09
End infusion 1.97 0.19 1.88 0.13 1.38 0.19"' 1.69 0.25 1.88 0.19"
End recovery 1.94 0.19 1.94 0.13 1.41 0.19b,c 1.66 0.22,d 1.72 0.l9b,d
Glucose, mM
Control 5.4 0.4 5.0 0.3 5.5 0.2 5.1 0.3 5.2 0.6
End infusion 6.5 0.4 5.6 0.4 4.6 0.4"" 5.8 0.3" 5.8 0.5"
End recovery 6.4 0.4 5.9 0.4 5.1 0.4b,c 5.8 0.2" 6.4 0.7"
The experimental design, number of dogs, presentation of data, and notation of symbols are the same as in Table 1.
lowing organic anion infusions to those following chloride
infusion are given in Table 5.
Discussion
In the present work, serum sodium levels, corrected for
dilutional effects, suggest that large differences exist between
the distribution of sodium with sodium chloride infusion and
sodium with sodium acetate infusion. On the average, a greater
distribution space of sodium is implied with acetate infusion
than with infusions of either bicarbonate, lactate, or pyruvate.
Such differences in sodium distribution may reflect the number
of body cells available for metabolism of the anion in question.
The dilution of serum albumin also varied with the anion
infused and, thereby, indicated differences in the accessibility
of cells to the anions infused.
The effectiveness with which cells metabolize any organic
anion is demonstrated by the rate of bicarbonate generation.
Infusion of lactate was associated with a significantly slower
rate of bicarbonate generation than the infusions of either
acetate or pyruvate. It is likely that the additional step required
of metabolizing lactate to pyruvate in the presence of a particu-
larly unfavorable cytosolic redox state (NADH:NAD+) is
partially responsible [17]. This step is suggested by the lesser
rise in blood pyruvate concentration with lactate infusion than
in blood lactate concentration with pyruvate infusion (cf. Table
4).
Use of controlled ventilation in the present study allowed
observation of changes in blood gases arising from metabolism.
For example, the generation of dissolved carbon dioxide
(PaCO2) was substantially greater with infusion of pyruvate
than with acetate infusion. Yet, the generation rates of bicar-
bonate were identical. The net effect, therefore, is hyperbicar-
bonatemia with minimal alkalemia (pyruvate) versus hyperbi-
carbonatemia with marked alkalemia (acetate). Had the experi-
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Table 4. Arterial blood pyruvate, lactate, acetoacetate, and 3-hydroxybutyrate following chloride,
bicarbonate, acetate, lactate, and pyruvate infusionsa
Infusate
Chloride Bicarbonate Acetate Lactate Pyruvate
Pyruvate, M
Control 67 10 67 22 65 4 77 12 62 10
End infusion 83 19 100 37 50 8 240 31"" 319 12Ia
End recovery 78 18 97 24 78 8 197 42b,d 191 34b.,d
Lactate, mM
Control 0.88 0.12 0.99 0.28 0.85 0.06 0.98 0.14 0.78 0.13
End infusion 1.07 0.19 1.61 0.37 1.43 0.12 10.27 2.68" 5.85 0.62'
End recovery 0.95 0.15 1.34 0.31 1.06 0.08 5.43 l.95b,c 3.09 0.50
Acetoacetate, ILM
Control 25 5 21 4 16 2 16 4 9 2
End infusion 28 6 28 5 140 27bc 21 4d 21 7"
End recovery 30 7 28 5 41 10 25 5 16 5d
3-Hydroxybutyrate, LM
Control 18 7 31 6 25 13 16 6 11 2
End infusion 21 8 46 13 224 20bc 10 5" 13 3d
End recovery 19 8 35 6 59 18" 21 6d 17 6d
The experimental design, number of dogs, presentation of data, and notation of symbols are the same as in Table 1.
Table 5. Arterial blood alanine and plasma acetate and insulin following chloride, bicarbonate, acetate, lactate, and pyruvate infusionsa
Infusate
Chloride Bicarbonate Acetate Lactate Pyruvate
Alanine, mM
Control 0.28 0.03 0.25 0.05 0.33 0.09 0.40 0.05 0.26 0.03
End infusion 0.28 0.03 0.19 0.03 0.15 003" 0.54 008b,c,d 0.37 003c,d
End recovery 0.25 0.03 0.18 0.03 0.12 0.02 0.49 009b.c,d 0.41 0•02b,c.d
Acetate, M
Control 8 3 17 2 12 2 21 6 23 5
End infusion 11 4 22 3 5391 1379b,c 72 I8 148 26b.e.d,
End recovery 11 3 14 2 36 8"' 50 l4lc 48 8
Insulin, lU/mi
Control 15 5 14 2 18 3 7 2 5 I
End infusion 12 3 14 3 22 13 6 9 2
End recovery 10 3 10 2 9 2 13 7 Il 4b,d
a The experimental design, number of dogs, presentation of data, and notation of symbols are the same as in Table 1.
mental animals in our studies been spontaneously breathing, the
respiratory drive of the animals may have obscured seeing the
large generation of dissolved carbon dioxide with pyruvate
metabolism, short of determining carbon dioxide in the expired
air.
The original work of Mudge, Manning, and Gilman [181,
comparing equimolar infusions of acetate and bicarbonate in
dog and man to arrive at the oxidation rate of acetate, ignored
the relationship between the generation rates of bicarbonate
and dissolved carbon dioxide. Their work focused on whole
blood total carbon dioxide in the spontaneously breathing
anesthetized dog. They state, though their bicarbonate infusion
data in dogs are not shown, that total carbon dioxide rose
equally with acetate and bicarbonate infusions. Summating
PaCO2 and arterial bicarbonate levels to approximate total
carbon dioxide, our results show that total carbon dioxide at the
end of infusion of acetate was 31.2 1.2 mmoles/liter, a value
considerably less than with bicarbonate infusion, 35.8 1.5
mmoles/liter (2P < 0.05). This difference in results may reflect
either substrate limitations due to the fasting state (48 hr) of our
animals or the rate of acetate infusion. The infusion rate in our
experiments was about 2.7 times greater on a molar basis than
that used by Mudge, Manning, and Gilman. While serial plasma
acetate levels were not determined during the infusion of
sodium acetate, the fact that plasma acetate levels were still
significantly greater than control values 30 mm into the recov-
ery (2P < .025) suggests that the rate of acetate infusion in our
studies exceeded its rate of metabolism. The half-life of acetate
in dogs is short enough (3.8 0.5 mm [19]) that, had the
maximum rate of acetate metabolism not been exceeded, plas-
ma levels should have been reduced to control levels by the end
of the recovery period.
In the presence of controlled ventilation, Pa02 should be a
reasonable indicator of oxygen consumption and, hence, the
rate of organic anion metabolism. Of the organic anions infused
in our study, acetate had the most profound effect on oxygen
consumption. That acetate metabolism increases oxygen con-
sumption has been well described [6]. Hypoxemia has been
described during hemodialysis and has been variously ascribed
to microemboli [20], pulmonary sequestration of leukocytes
[21], and depressed ventilation [22, 23]. Our work, along with
that of Liang and Lowenstein [6], suggests that oxidative
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metabolism of acetate may be the most significant contributing
factor to hemodialysis related hypoxemia. This is supported by
the recent observations of Jones, Broadfield, and Parsons [24]
who noted a marked decrease in Pa02 in patients undergoing
acetate hemodialysis while being mechanically ventilated at a
constant rate and who displayed no change in PaCO2. The fact
that bicarbonate infusion in our studies depressed Pa02 implies
that either hemoglobin affinity for oxygen increased in the
presence of alkalemia (Bohr effect) or the increase in PaCO2,
reflected by the increase in PaCO2, physically displaced oxygen
at the alveolar level during fixed ventilation and, thereby,
reduced Pa02.
It is apparent that changes in serum potassium and phospho-
rus are dependent on the anion infused. Chloride infusion
created a mild acidemia, a controversial phenomenon referred
to as "dilutional" acidosis [25], and was associated with a rise
in both serum potassium and phosphorus. A similar movement
of potassium and phosphorus out of cells in response to acidosis
has previously been demonstrated following exercise [261. To
the contrary, all organic anion infusions caused a shift of
potassium into cells while variable effects on serum phosphorus
were noted. This suggests that a process in addition to acid-base
changes, particularly with acetate infusion, contributed to the
shifts in potassium and phosphorus, namely, a metabolic redis-
tribution phenomenon not unlike that observed with the intra-
venous administration of glucose and insulin [27, 28].
Of the organic anions infused, acetate was the only one
observed to cause a decrease in plasma glucose. The hypogly-
cemic effects of acetate occurred in our experiments in the face
of sustained serum insulin levels during acetate infusion. How-
ever, the serum insulin levels fell significantly on cessation of
infusion. This suggested that acetate, or another metabolite,
may have been acting as an insulin secretogogue, uncoupling
the usual feedback relationship between insulin and glucose. An
insulin secretogogue role for acetoacetate has been established
[291 and, since acetoacetate levels rose so remarkably with
acetate infusion in our studies, the insulinogenic effect of
acetate may have been indirect. The infusions of the remaining
anions, including chloride, were also associated with sustained
insulin levels. However, in each of those instances, glucose was
rising: with lactate and pyruvate, due to production of glucose
[171; with bicarbonate, for reasons not clearly understood; and,
with chloride, perhaps due to the mild acidemia creating insulin
resistance, not unlike the findings by DeFronzo and Beckles
[301 after administering ammonium chloride in humans.
Infusion of acetate resulted in a moderate but significant
decrease in blood alanine and rise in blood lactate levels. But
more spectacularly, acetate was the only anion infused to cause
large increases in acetoacetate and 3-hydroxybutyrate. This has
been shown previously in the human in nondialysis studies [31].
These findings, taken collectively, suggest that the redox state
of the animals, principally mitochondrial NADH:NAD+, and
accumulated acetyl-CoA secondary to acetate infusion favored,
simultaneously, the conversion of pyruvate to lactate and of
acetoacetate, derived from condensation of acetyl-CoA, to 3-
hydroxybutyrate. We cannot tell whether alanine levels fell due
to enhanced conversion to pyruvate or to decreased production
as might occur with an insulin secretogogue effect during
acetate infusion.
It is of interest that the infusions of lactate and pyruvate were
associated with small but significant increases in plasma acetate
levels. Net acetate production has been described in the human
[32], and it may be that metabolism of these anions contribute to
the production of acetate.
With the exceptions of increased plasma glucose levels, a rise
in blood lactate and a minimal decline in blood alanine levels,
sodium bicarbonate infusion seemed to have little effect on
intermediary metabolism.
While appropriate restraint has to be shown in transferring
findings in animal experiments to the clinical setting, similar
effects on intermediary metabolism to those seen with sodium
acetate infusion in our study have been described in hemodialy-
sis with dialysates containing acetate [2, 3, 141. It would seem
reasonable to conclude from the present study that acetate
metabolism, as well as dialysis, per Se, may contribute to many
of the metabolic perturbations normally observed during dialy-
sis. This would include decreased serum potassium and phos-
phorus due to concomitant redistribution of these two elements
into body cells and undesired increases in intermediary metabo-
lites such as lactate, acetoacetate, and 3-hydroxybutyrate. In
the circumstance of dialysis, the diffusive losses of substantial
quantities of these three anions, as stated earlier, would pre-
clude appropriate base repletion. The redistribution of potassi-
um and phosphorus would prohibit appropriate therapeutic
reduction in body burden of these two substances, a purpose for
which dialysis is routinely prescribed. The present results,
demonstrating a depressant effect of acetate on plasma glucose,
indicate that glucose should be a common additive in acetate
dialysates, particularly in the fasting patient. We also note that
acetate was the only organic anion of the four investigated
which caused a marked decline in blood pressure. This observa-
tion on acetate was made as early as 1928 by Bauer and
Richards [33] and has been reaffirmed in recent times [6, 34].
The choice of an organic anion for use as a base substitute in
clinical hemodialysis is dependent firstly on the anion being
sufficiently soluble to permit the required dialysate concentra-
tion to be obtained and secondly on it having a sufficient
permeability through the dialyzer membrane in comparison to
bicarbonate. All organic anions considered in our study meet
these requirements [35]. The choice of anion is then predicated,
to some extent, on whether or not it can be metabolized rapidly
enough to offset the phenomenal diffusive losses of bicarbonate
which accompany dialysis. Such losses may measure up to 3
mmoles/min with highly efficient dialysis [3]. Our data indicate
that lactate would be a poor choice in this regard. If a
nonbicarbonate base substitute must be used in dialysis, our
studies suggest that pyruvate, except for substantially increas-
ing blood lactate levels and, thereby, the likelihood of base
inequality, might be the preferred choice. Pyruvate is equal to
acetate in the generation of bicarbonate and, because of its
glucogenic properties, its use might also obviate the need for
addition of glucose to the dialysate. Unfortunately, the physico-
chemical nature of sodium pyruvate may prohibit its clinical use
in that it is unstable in solution at room temperature [36].
In the final analysis, it would appear that no organic anion,
including succinate, which has been studied for its lack of
cardiovascular effects by Kirkendol, Pearson, and Gonzalez
[37], could serve the dialysis patient better than bicarbonate.
This may be reflected in the current resurgence of interest in the
clinical use of bicarbonate dialysis. In spite of calcium and
magnesium solubility problems with bicarbonate dialysis [11,
the dialysate to blood diffusion gradient for bicarbonate could
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be kept quite small in the base-repleted patient. One would,
therefore, be unlikely to see development of a major alkalemia
or a significant increment in any intermediary metabolite,
including blood lactate, during bicarbonate dialysis.
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